Expert Series: Ultra-Rare Mitochondrial Diseases: Development Challenges and Opportunities
October 6, 2023
@
12:00 pm
-
1:00 pm EDT
Join CEO of Stealth Biotherapeutics Reenie McCarthy, and special guest Shelley Bowen, Director of Family Services and Advocacy for the Barth Syndrome Foundation, as they discuss the health equity challenges faced within the ultra-rare disease space, particularly for mitochondrial targeted therapies, and the potential solutions to overcome these obstacles in therapy development.
Reenie McCarthy is the Chief Executive Officer and a member of the Board of Stealth BioTherapeutics. Reenie is a 20+ year veteran of the investment team of Morningside, Stealth’s principal investor, with extensive experience working with private nonclinical and clinical stage companies developing drugs across a broad spectrum of therapeutic areas.
We still have tickets for the Sandra K. Russell Derby Day Benefit for Mito on Saturday, May 3, 2025 — the hottest Derby Day event in Boston!
Enjoy big hats, bow ties, incredible silent and live auction items, and signature mint juleps while helping raise money to improve the lives of patients and families affected by mitochondrial disease.